PubRank

J Blomberg

Author PubWeight™ 85.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000 2.81
2 Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet 1974 2.16
3 The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope. J Virol 1990 1.76
4 Hemolysis-in-gel and neutralization tests for determination of antibodies to mumps virus. J Clin Microbiol 1976 1.63
5 Epidemic acute diarrhoea in adults associated with infantile gastroenteritis virus. Lancet 1978 1.55
6 Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. Proc Natl Acad Sci U S A 1988 1.55
7 O-glycosidic carbohydrate-peptide linkages of Herpes simplex virus glycoproteins. Arch Virol 1981 1.53
8 Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. Lancet 1986 1.53
9 Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues. J Virol 1993 1.52
10 Specificity of Fc receptors induced by herpes simplex virus type 1: comparison of immunoglobulin G from different animal species. J Virol 1985 1.39
11 Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol 1985 1.39
12 Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J Gen Virol 1992 1.33
13 Diversity of human endogenous retrovirus class II-like sequences. J Gen Virol 1999 1.32
14 Evolution of human endogenous retroviral sequences: a conceptual account. Cell Mol Life Sci 2008 1.26
15 Identification of novel porcine endogenous betaretrovirus sequences in miniature swine. J Virol 2001 1.18
16 Usefulness of real-time PCR for lytA, ply, and Spn9802 on plasma samples for the diagnosis of pneumococcal pneumonia. Clin Microbiol Infect 2009 1.17
17 Differences in mechanisms of transformation by independent feline sarcoma virus isolates. J Virol 1981 1.16
18 Viral antibody screening system that uses a standardized single dilution immunoglobulin G enzyme immunoassay with multiple antigens. J Clin Microbiol 1983 1.15
19 Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis. BMJ 1998 1.12
20 Snyder-Theilen feline sarcoma virus P85 contains a single phosphotyrosine acceptor site recognized by its associated protein kinase. J Virol 1981 1.11
21 Abelson murine leukaemia virus transformation involves loss of epidermal growth factor-binding sites. Nature 1980 1.05
22 Search for DNA of exogenous mouse mammary tumor virus-related virus in human breast cancer samples. J Gen Virol 2007 1.00
23 A sequence in the carboxyl terminus of the HIV-1 matrix protein is highly similar to sequences in membrane-associated proteins of other RNA viruses: possible functional implications. New Biol 1990 1.00
24 Structure and genomic organization of a novel human endogenous retrovirus family: HERV-K (HML-6). J Gen Virol 1997 0.99
25 Varieties of long-term outcome among patients in psychoanalysis and long-term psychotherapy. A review of findings in the Stockholm Outcome of Psychoanalysis and Psychotherapy Project (STOPP). Int J Psychoanal 2000 0.98
26 Antibodies to a putative HIV gp41 immunosuppressive peptide, pHIVIS (583-599), do not correlate significantly with outcome in HIV infection. AIDS 1990 0.97
27 Is quantitative PCR for the pneumolysin (ply) gene useful for detection of pneumococcal lower respiratory tract infection? Clin Microbiol Infect 2009 0.97
28 Involvement of a high-molecular-weight polyprotein translational product of Snyder-Theilen Feline sarcoma virus in malignant transformation. J Virol 1981 0.97
29 Spliced human endogenous retroviral HERV-H env transcripts in T-cell leukaemia cell lines and normal leukocytes: alternative splicing pattern of HERV-H transcripts. J Gen Virol 1997 0.96
30 Patterns of antibodies to human immunodeficiency virus proteins in different subclasses of IgG. J Infect Dis 1987 0.96
31 Stillbirths and intrauterine infection, histologic chorioamnionitis and microbiological findings. Int J Gynaecol Obstet 1996 0.96
32 Isolation of a human endogenous retroviral HERV-H element with an open env reading frame. Virology 1999 0.96
33 SYBR Green real-time reverse transcription-polymerase chain reaction assay for the generic detection of coronaviruses. Arch Virol 2006 0.95
34 Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994. J Acquir Immune Defic Syndr Hum Retrovirol 1997 0.95
35 Differential expression of human endogenous retroviral sequences similar to mouse mammary tumor virus in normal peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1996 0.95
36 Human immunoglobulin class and subclass specificity of Fc receptors induced by herpes simplex virus type 1. J Virol 1984 0.93
37 Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus. Arthritis Rheum 1996 0.93
38 Classification of highly similar crude oils using data sets from comprehensive two-dimensional gas chromatography and multivariate techniques. J Chromatogr A 2005 0.92
39 Subtyping of herpes simplex virus. Acta Pathol Microbiol Scand B 1975 0.91
40 Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. Int J Cancer 1989 0.90
41 Erythromycin and phenoxymethylpenicillin (penicillin V) in the treatment of respiratory tract infections as related to microbiological findings and serum C-reactive protein. Scand J Infect Dis 1991 0.90
42 CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjögren's syndrome. Clin Exp Rheumatol 1996 0.88
43 Sequence variation of human endogenous retrovirus ERV9-related elements in an env region corresponding to an immunosuppressive peptide: transcription in normal and neoplastic cells. J Virol 1993 0.87
44 Antibodies to human adult T cell leukaemia virus type I associated antigens in Swedish leukaemia patients and blood donors. Br J Haematol 1985 0.87
45 Anti-STLV-IIImac reactivity in HIV seropositive individuals in Sweden. Lancet 1986 0.87
46 Transcription of human endogenous retroviral sequences related to mouse mammary tumor virus in human breast and placenta: similar pattern in most malignant and nonmalignant breast tissues. AIDS Res Hum Retroviruses 1997 0.85
47 Two domains of the Borna disease virus p40 protein are required for interaction with the p23 protein. J Gen Virol 1998 0.85
48 Intrauterine death and infections during pregnancy. Int J Gynaecol Obstet 1995 0.85
49 The rapid molecular subtyping and pathotyping of avian influenza viruses. J Virol Methods 2008 0.84
50 Characterization of human MMTV-like (HML) elements similar to a sequence that was highly expressed in a human breast cancer: further definition of the HML-6 group. Virology 1999 0.84
51 Differential pattern of oncogene and beta-actin expression in leukaemic cells from AML patients. Br J Haematol 1987 0.84
52 Glycosphingolipids of a green monkey kidney cell line (GMK AH-1). Evidence for a novel pentaglycosylceramide based on globotetraosylceramide. Biochim Biophys Acta 1982 0.84
53 Sequence evolution and cross-reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection. J Med Virol 2001 0.83
54 Hospital-based study of sexually transmitted diseases at Murewa rural district hospital, Zimbabwe 1991-1992. Sex Transm Dis 1995 0.83
55 Prevalence of blood-borne viral infections (cytomegalovirus, human herpesvirus-6, human herpesvirus-7, human herpesvirus-8, human T-cell lymphotropic virus-I/II, human retrovirus-5) among blood donors in Latvia. Ann Hematol 2001 0.83
56 Telomeric location of retroviral oncogenes in humans. Hereditas 1991 0.82
57 Increased incidence of Kaposi sarcoma in Sweden before the AIDS epidemic. Eur J Cancer 1990 0.82
58 Recent enterovirus infection in type 1 diabetes: evidence with a novel IgM method. J Med Virol 2007 0.82
59 Diagnostic value of abdominal drainage in individual risk assessment of pancreatic fistula following pancreaticoduodenectomy. Br J Surg 2013 0.81
60 Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera. J Med Virol 1999 0.81
61 Purification of herpes simplex virus. J Gen Virol 1974 0.81
62 Uptake of amplifiable fragments of retrotransposon DNA from the human alimentary tract. Mol Genet Genomics 2003 0.81
63 Coamplification and dispersion of adjacent human endogenous retroviral HERV-H and HERV-E elements; presence of spliced hybrid transcripts in normal leukocytes. Virology 1998 0.81
64 Increased immunoglobulin G, but not M, binding to endogenous retroviral antigens in HIV-1 infected persons. J Med Virol 2000 0.80
65 Comprehensive multi-dimensional chromatographic studies on the separation of saturated hydrocarbon ring structures in petrochemical samples. J Chromatogr A 2005 0.80
66 VIRUS--a laboratory information system for clinical virology. Methods Inf Med 1979 0.80
67 Human retrovirus 5 sequences in peripheral blood cells of patients with B-cell non-Hodgkin's lymphoma. Int J Cancer 2000 0.79
68 Hospital teaching status and volume related to mortality after pancreatic cancer surgery in a national cohort. Br J Surg 2015 0.79
69 Functional aspects of odontocete head oil lipids with special reference to pilot whale head oil. Prog Chem Fats Other Lipids 1978 0.78
70 Tropical spastic paraparesis associated with human T lymphotropic virus type I in an east African naturalised in Sweden. Br Med J (Clin Res Ed) 1987 0.78
71 Human retrovirus type 5 sequences in non-Hodgkin's lymphoma of T cell origin. AIDS Res Hum Retroviruses 2001 0.78
72 Characterization of herpes simplex virus type 1-induced Fc receptor in its interaction with rabbit immunoglobulin G (IgG). APMIS 1990 0.78
73 Determination of rubella immunity by latex agglutination: its place in clinical routines. Scand J Infect Dis 1984 0.78
74 Streptococcal protein G: a sensitive tool for detection of antibodies to human immunodeficiency virus proteins in Western blot analysis. Eur J Clin Microbiol 1987 0.77
75 A novel serological technique: polymerase chain reaction enhanced immunoassay. Application to enterovirus IgM diagnosis. J Virol Methods 1999 0.77
76 Identification of tryptic peptides unique to a 110,000-molecular weight polyprotein encoded by the T-8 isolate of murine leukemia virus. J Exp Med 1980 0.77
77 Three-dimensional structure and antigenicity of transmembrane-protein peptides of the human immunodeficiency virus type 1. Effects of a neutralization-escape substitution. FEBS Lett 1993 0.77
78 Comparison of comprehensive two-dimensional gas chromatography and gas chromatography--mass spectrometry for the characterization of complex hydrocarbon mixtures. J Chromatogr A 2000 0.77
79 Serological evaluation of possible exposure to Ljungan virus and related parechovirus in autoimmune (type 1) diabetes in children. J Med Virol 2015 0.76
80 HTLV-II among injecting drug users in Stockholm. Scand J Infect Dis 1994 0.76
81 Structural prerequisites for intersubtype B and D antigenicity of the third variable envelope region (V3) of human immunodeficiency virus type 1. J Infect Dis 2000 0.76
82 A cluster of continuous antigenic structures in the transmembrane protein of HIV-1: individual patterns of reactivity in human sera. Mol Immunol 1991 0.76
83 Continuity and discontinuity in the anti-V3 IgG response of human immunodeficiency virus type 1-infected persons in a cross-sectional and longitudinal study using synthetic peptides. J Infect Dis 1995 0.76
84 Purification of virions and nucleocapsids of herpes simplex virus by means of metrizamide and sodium metrizoate gradients. Arch Virol 1976 0.76
85 The humanized severe combined immunodeficient mouse as a model for primary human humoral response against HIV1 peptides. J Immunol Methods 1995 0.76
86 Immunoglobulin G antibodies binding to a synthetic peptide deduced from the nucleotide sequence of the env gene of HTLV I in patients with leukemia and rheumatoid arthritis, HLA sensitized persons and blood donors. Leuk Res 1985 0.75
87 Assessing surgical quality: comparison of general and procedure-specific morbidity estimation models for the risk adjustment of pancreaticoduodenectomy outcomes. World J Surg 2014 0.75
88 Seroepidemiology of human retroviruses in Ogun State of Nigeria. Scand J Infect Dis 1990 0.75
89 Intrauterine varicella: a report of two cases associated with hyper-A-immunoglobulinemia. Scand J Infect Dis 1981 0.75
90 Variations in lipid composition and sound velocity in melon from the North Atlantic Pilot whale, globicephala melaena melaena. Lipids 1976 0.75
91 Human and murine monoclonal antibodies directed against a conserved sequence from gp41 (aa583-599) of human immunodeficiency virus type 1. Res Virol 1992 0.75
92 [Findings of viruses among foreign adopted children]. Lakartidningen 1974 0.75
93 Hepatitis B virus-DNA in the serum of patients followed-up longitudinally with acute and chronic hepatitis B. J Med Virol 1985 0.75
94 Studies on the attachment of herpes simplex virus. Effect of trypsin treatment. Arch Virol 1979 0.75
95 Ultrasonic studies on the head oil of the North Atlantic pilot whale (Globicephala melaena melaena). J Acoust Soc Am 1976 0.75
96 [Ideology before common sense in HIV testing!]. Lakartidningen 1994 0.75
97 Tyrosine phosphorylation sites common to transforming proteins encoded by Gardner and Snyder-Theilen FeSV. Virology 1982 0.75
98 HTLV in Sweden: antibodies to HTLV I antigens in experimental monkeys and their caretakers. Scand J Infect Dis 1985 0.75
99 Pediatric gastroenteritis in primary care and in hospitalized patients. Scand J Prim Health Care 1987 0.75
100 The long leader sequence of the mouse ornithine decarboxylase mRNA, previously suspected to be a cloning artifact, is probably a product of recombination with MuLV-like retrovirus. Gene 1991 0.75
101 Unusual lipids. II. Head oil of the north atlantic pilot whale, Globicephala melaena melaena. Lipids 1974 0.75
102 Retroviral RNA related to ERV9/MSRV in a human serum: a new sequence variant. AIDS Res Hum Retroviruses 1999 0.75
103 A study of glare with the aid of optokinetic nystagmus. Acta Ophthalmol (Copenh) 1967 0.75
104 [highly pathogenic exotic virus diseases]. Lakartidningen 1981 0.75
105 [Neurologic diseases associated with HTLV-I infections]. Lakartidningen 1989 0.75
106 Differential IgG subclass responses to epitopes in transmembrane protein of HIV-1. Viral Immunol 1990 0.75
107 Broad spectrum of time of detection, primary symptoms and disease progression in infants with HIV-1 infection. Eur J Clin Microbiol Infect Dis 2001 0.75
108 Absence of host-cell influence on binding specificity of herpes simplex virus type 1 induced Fc receptor. Acta Pathol Microbiol Immunol Scand C 1987 0.75
109 Studies on glycopeptides of Herpes simplex virus infected cells. Arch Virol 1977 0.75
110 [HTLV-I--a prototype in a growing group of leukemogenic viruses]. Lakartidningen 1989 0.75
111 Primary in vitro immunization with multimeric synthetic peptides of HIV-1 envelope glycoproteins: generation of neutralizing human monoclonal antibodies. J Immunol Methods 1994 0.75
112 Antibody prevalence against rubella among hospital personnel in Nigeria: implications for health care system and immunisation policy. Acta Trop 1990 0.75
113 Acetylation analysis of saccharides. 2. Microanalysis of neutral glycosphingolipids by means of acetylation with radioactive acetic anhydride. Anal Biochem 1978 0.75
114 Anti-herpes simplex type 1 activity in IgG subclasses produced systemically and intrathecally in patients with herpes encephalitis. J Neurol 1986 0.75